Showing results (1321-1330 of 1,469) with videos related to
Sort By:
Pageof 147
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS RegisterPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.EFSA Journal. European Food Safety Authority|July 28, 2023
Peer review of the pesticide risk assessment of the active substance glyphosate, Fernando Álvarez, Maria Arena, et al.Physical Review Letters|October 10, 2006
Active-feedback control of the magnetic boundary for magnetohydrodynamic stabilization of a fusion plasmaR Paccagnella, S Ortolani, P Zanca, et al.Journal of Neuromuscular Diseases|February 16, 2024
The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient CardiomyopathyLuca Bello, Daniele Sabbatini, Aurora Fusto, et al.Geroscience|July 20, 2026
Performance of the SmartMe&You serious video games for home telemonitoring is related to cognitive status and resting-state electroencephalographic markers in healthy and Parkinson's disease participantsClaudio Del Percio, Roberta Lizio, Mina De Bartolo, et al.EFSA Journal. European Food Safety Authority|November 21, 2022
Re-evaluation of neohesperidine dihydrochalcone (E 959) as a food additive, Maged Younes, Gabriele Aquilina, et al.Aging Cell|December 18, 2013
The co-occurrence of mtDNA mutations on different oxidative phosphorylation subunits, not detected by haplogroup analysis, affects human longevity and is population specificNicola Raule, Federica Sevini, Shengting Li, et al.American Journal of Hematology|April 16, 2026
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International ExperienceBruno Fattizzo, Elisa Sambruna, Yoshitaka Miyakawa, et al.Journal of Neurology|June 28, 2021
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective studyClara G Chisari, Giancarlo Comi, Massimo Filippi, et al.Multiple Sclerosis and Related Disorders|October 26, 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Irene Schiavetti, Roberto Bergamaschi, et al.Pageof 147